Efficacy and Safety of Semaglutide Once-weekly Versus Placebo as add-on to Basal Insulin Alone or Basal Insulin in Combination With Metformin in Subjects With Type 2 Diabetes
Public ClinicalTrials.gov record NCT02305381. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This trial is conducted in Asia, Europe and the United States of America (USA). The aim of the trial is to investigate efficacy and safety of semaglutide once weekly versus placebo as add-on to basal insulin alone or basal insulin in combination with metformin in subjects with type 2 diabetes.
Study identification
- NCT ID
- NCT02305381
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 397 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2014
- Primary completion
- Nov 20, 2015
- Completion
- Nov 20, 2015
- Last update posted
- Jun 10, 2019
2014 – 2015
United States locations
- U.S. sites
- 72
- U.S. states
- 27
- U.S. cities
- 66
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Novo Nordisk Investigational Site | Phoenix | Arizona | 85018 | — |
| Novo Nordisk Investigational Site | Anaheim | California | 92801 | — |
| Novo Nordisk Investigational Site | Fresno | California | 93720 | — |
| Novo Nordisk Investigational Site | Lomita | California | 90717 | — |
| Novo Nordisk Investigational Site | Los Angeles | California | 90057-3550 | — |
| Novo Nordisk Investigational Site | Northridge | California | 91325 | — |
| Novo Nordisk Investigational Site | Poway | California | 92064 | — |
| Novo Nordisk Investigational Site | Riverside | California | 92506 | — |
| Novo Nordisk Investigational Site | Roseville | California | 95661 | — |
| Novo Nordisk Investigational Site | San Ramon | California | 94583 | — |
| Novo Nordisk Investigational Site | Van Nuys | California | 91405 | — |
| Novo Nordisk Investigational Site | Walnut Creek | California | 94598 | — |
| Novo Nordisk Investigational Site | Waterbury | Connecticut | 06708 | — |
| Novo Nordisk Investigational Site | Bradenton | Florida | 34201 | — |
| Novo Nordisk Investigational Site | Fleming Island | Florida | 32003 | — |
| Novo Nordisk Investigational Site | Jacksonville | Florida | 32204 | — |
| Novo Nordisk Investigational Site | Port Charlotte | Florida | 33952 | — |
| Novo Nordisk Investigational Site | Spring Hill | Florida | 34609 | — |
| Novo Nordisk Investigational Site | Tampa | Florida | 33634 | — |
| Novo Nordisk Investigational Site | Roswell | Georgia | 30076 | — |
| Novo Nordisk Investigational Site | Chicago | Illinois | 60607 | — |
| Novo Nordisk Investigational Site | Chicago | Illinois | 60611 | — |
| Novo Nordisk Investigational Site | Gillespie | Illinois | 62033 | — |
| Novo Nordisk Investigational Site | Skokie | Illinois | 60077 | — |
| Novo Nordisk Investigational Site | Avon | Indiana | 46123 | — |
| Novo Nordisk Investigational Site | Greenfield | Indiana | 46140 | — |
| Novo Nordisk Investigational Site | Indianapolis | Indiana | 46254 | — |
| Novo Nordisk Investigational Site | Muncie | Indiana | 47304 | — |
| Novo Nordisk Investigational Site | Council Bluffs | Iowa | 51501 | — |
| Novo Nordisk Investigational Site | Overland Park | Kansas | 66209 | — |
| Novo Nordisk Investigational Site | Topeka | Kansas | 66606 | — |
| Novo Nordisk Investigational Site | Lexington | Kentucky | 40503 | — |
| Novo Nordisk Investigational Site | Paducah | Kentucky | 42003 | — |
| Novo Nordisk Investigational Site | Metairie | Louisiana | 70002 | — |
| Novo Nordisk Investigational Site | Rockville | Maryland | 20852 | — |
| Novo Nordisk Investigational Site | Waltham | Massachusetts | 02453 | — |
| Novo Nordisk Investigational Site | Ann Arbor | Michigan | 48106 | — |
| Novo Nordisk Investigational Site | Flint | Michigan | 48532 | — |
| Novo Nordisk Investigational Site | Kalamazoo | Michigan | 49009 | — |
| Novo Nordisk Investigational Site | Jackson | Mississippi | 39209 | — |
| Novo Nordisk Investigational Site | Las Vegas | Nevada | 89103 | — |
| Novo Nordisk Investigational Site | Las Vegas | Nevada | 89128 | — |
| Novo Nordisk Investigational Site | Teaneck | New Jersey | 07666 | — |
| Novo Nordisk Investigational Site | Albuquerque | New Mexico | 87102 | — |
| Novo Nordisk Investigational Site | West Seneca | New York | 14224 | — |
| Novo Nordisk Investigational Site | Cincinnati | Ohio | 45245 | — |
| Novo Nordisk Investigational Site | Cincinnati | Ohio | 45246 | — |
| Novo Nordisk Investigational Site | Cincinnati | Ohio | 45255 | — |
| Novo Nordisk Investigational Site | Dayton | Ohio | 45439 | — |
| Novo Nordisk Investigational Site | Kettering | Ohio | 45429 | — |
| Novo Nordisk Investigational Site | Oklahoma City | Oklahoma | 73162-4704 | — |
| Novo Nordisk Investigational Site | Yukon | Oklahoma | 73099 | — |
| Novo Nordisk Investigational Site | Levittown | Pennsylvania | 19056-2404 | — |
| Novo Nordisk Investigational Site | Philadelphia | Pennsylvania | 19114 | — |
| Novo Nordisk Investigational Site | Athens | Tennessee | 37303 | — |
| Novo Nordisk Investigational Site | Bristol | Tennessee | 37620-7352 | — |
| Novo Nordisk Investigational Site | Chattanooga | Tennessee | 37411 | — |
| Novo Nordisk Investigational Site | Kingsport | Tennessee | 37660 | — |
| Novo Nordisk Investigational Site | Amarillo | Texas | 79106 | — |
| Novo Nordisk Investigational Site | Dallas | Texas | 75251 | — |
| Novo Nordisk Investigational Site | Dallas | Texas | 75390-9302 | — |
| Novo Nordisk Investigational Site | Fort Worth | Texas | 76132 | — |
| Novo Nordisk Investigational Site | Houston | Texas | 77008 | — |
| Novo Nordisk Investigational Site | Hurst | Texas | 76054 | — |
| Novo Nordisk Investigational Site | Katy | Texas | 77450 | — |
| Novo Nordisk Investigational Site | Mesquite | Texas | 75149 | — |
| Novo Nordisk Investigational Site | San Antonio | Texas | 78224 | — |
| Novo Nordisk Investigational Site | Sugar Land | Texas | 77478 | — |
| Novo Nordisk Investigational Site | Sugar Land | Texas | 77479 | — |
| Novo Nordisk Investigational Site | Bountiful | Utah | 84010 | — |
| Novo Nordisk Investigational Site | Richmond | Virginia | 23219 | — |
| Novo Nordisk Investigational Site | Kenosha | Wisconsin | 53144 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 27 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02305381, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 10, 2019 · Synced Sep 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02305381 live on ClinicalTrials.gov.